THE CME CREDIT FOR THIS ACTIVITY HAS EXPIRED.
Depression in the Elderly
for 1 AMA PRA Category 1 Credit™
University of Alabama
Division of Continuing Medical Education,
Division of Gerontology, Geriatrics, and
Palliative Care, and
The Center for Aging
Date: October 22, 2007
Date: October 22, 2010
completion of this CME activity,
physicians and other healthcare professionals
should be able to:
- Recognize depression in the elderly, its clinical manifestations, risk factors and prevalence.
- Understand the importance of developing systematic approaches to monitor patient responses, side effects and progress.
- Discuss the latest research on treatment-resistant depression.
- Summarize recent findings on non-pharmacologic therapies for treatment-resistant depression.
- Recognize electrolyte imbalances due to antidepressants.
- Recognize the signs and symptoms of withdrawal.
|Top of Page
AND CONTRIBUTING AUTHORS:
R. Curtis, PhD
Assistant Professor, Geriatric Education
Richard V. Sims, MD
Associate Professor of Medicine
Samina Uddin , MD
Geriatric Medicine Fellow
of Gerontology, Geriatrics and
University of Alabama at Birmingham
|Top of Page
faculty has no commercial affiliations
Because of the nature of preliminary
studies, some products mentioned are
unlabeled and investigational. Dosages,
indications, and methods of use of
drugs mentioned in this publication
may reflect the experience of the authors,
clinical literature, or other resources.
Therefore, please see the full prescribing
information before using any licensed
participate in this online course
for CME credit, please review the
objectives before beginning the program.
Complete the course and the self-assessment
test before October 22, 2010 to receive
CME credit. Your certificate will
then be available online. This process
should take approximately 1 hour.
University of Alabama School of
Medicine is accredited by the Accreditation
Council for Continuing Medical
Education to provide continuing
medical education for physicians.
University of Alabama School of
Medicine designates this educational
activity for a maximum of 1 AMA
PRA Category 1 Credit™.
Physicians should only claim credit
commensurate with the extent of
their participation in the activity.
boards of nursing in many states,
including Alabama, recognize Category
1 continuing medical education
courses as acceptable activities
for the renewal of license to practice
indications, and methods of use of
any drug referred to in this publication
may reflect the clinical experience
of the authors, clinical literature,
or other clinical resources. Therefore,
please see the full prescribing information
before using any product mentioned.
UAB is an equal opportunity/affirmative
Depression currently ranks as the fourth leading global disease burden. It is projected to rise to number two by the year 2020, second only to ischemic heart disease. Community studies have shown that 25% of elderly persons report depressive symptoms, but only 1% to 9% meet the criteria for major depression. However, prevalence varies according to the population being sampled. For example, higher prevalence rates are reported in the hospitalized elderly (36-46%) and those in long-term care facilities (10-22%)
Often depressed patients report unexplained physical symptoms as their chief complaints. Symptoms are more somatic than typical. For example, frequent office visits or use of medical services and persistent reports of pain, fatigue, insomnia, changes in appetite and unexplained gastrointestinal symptoms are characteristic of depression in older adults. Signs of social isolation and increased dependency are also common. Suicide rates are nearly twice as high in this group compared to younger patients. Sixty three percent of persons who commit suicide are white, elderly men, and eighty-five percent of them have an associated psychiatric or physical illness.
Diagnostic criteria for depression in the Diagnostic and Statistical Manual of Mental Disorders, fourth edition revised, (DSM-IV) should be able to identify most cases of depression. When a medical disorder or event is identified as causative, a diagnosis of mood disorder due to medical condition or event is made.
SIGECAPS': A Mmemonic for Symptoms of Major Depression and Systhymia 
|SIGECAPS=SIG + Energy + CAPSules
Sleep disorder (either increased or decreased sleep)
Interest deficit (anhedonia)
Guilt (worthlessness, hopelessness, regret)
Appetite disorder (either decreased or increased)
Psychomotor retardation or agitation
Several neurotransmitters regulate mood; dysregulation of serotonin (5HT) and norepinephrine (NE) in the brain are strongly associated with depression. Increased pain perception among depressed patients is probably due to this dysregulation in the brain and spinal cord. In fact, the imbalance of 5HT and NE probably explains the presence of both emotional and physical symptoms of depression in affected patients.
As of 2007, the evidence base for treatment of minor depression in the elderly is limited. The few randomized controlled trials focusing on the elderly patient suggest that antidepressant medication or depression-specific counseling methods have a relatively modest benefit. However, interpersonal psychotherapy and cognitive behavioral therapy have well-documented efficacy in randomized controlled trials, compared to medications, for elderly patients with mild to moderate depression. The combination of pharmacotherapy and psychotherapy has been shown to be the most efficacious treatment for severe depression, though results are mixed.
Approximately 2 million individuals in the United States will experience an inadequate response to treatment for depression during their lifetimes. The choice of antidepressant depends on symptoms, potential drug interactions and underlying medical illnesses. SSRIs are the first-line drugs of choice rather than the tricyclic antidepressants and MAOIs, due to better tolerance, lower incidence of sedation, little effect on cognition and fewer anticholinergic effects. Gastrointestinal symptoms in particular can be minimized by starting at lower dosages and taking the medicine with food. Sexual dysfunction is less frequent with fluvoxamine and non-SSRI agents like bupropion (Wellbutrin), mirtazapine (Remeron) and trazodone.
Mr. AB, a 69-year-old Caucasian male, comes to your office accompanied by his daughter. His chief complaints are “no energy”, memory problems, and worsening back pain for the past 6 months. He thinks that he is feeling fatigue due to his “poor back”.
His last visit with you was 10 months ago; since that time, he was admitted twice to the hospital. The first admission was with chest pain and the other with severe arthritic back pain following an automobile accident. His recent exercise MIBI was negative, and an MRI of the lumbosacral spine revealed osteoarthritis.
Mr. AB offers that his daughter has something that she wants to say. She reported that Mr. AB moved in with his younger brother after the death of his wife in 1996. Together they enjoyed dining out and socializing. Since his brother died 8 months ago, “Dad aged fast” the daughter added. She confides that for the past 6 months, Mr. AB has been exhibiting outbursts of anger and significant withdrawal from his usually active social life. He has always been a very independent and active person; the recent changes are atypical for him. He gradually began “to depend on others” and expects family members to do all his daily chores, including cooking and cleaning. He often forgets to eat meals prepared by the family, stating, “my back is too bad to warm up the food.” He has lost several pounds and begun to nap throughout the day.
Mr. AB has a history of hypertension controlled with lisinopril and is on a statin for hypercholesteremia. Two years ago, he underwent a diagnostic work-up, including a stress test and angiography, which revealed a lesion in the right coronary artery. A stent was placed.
Mr. AB never smoked or drank alcohol. His exercise routine has never been regular, and his intake of caffeine is moderate. Current medications include lisinopril 10 mg/d, atorvastatin 20 mg/d, Tylenol as needed and a baby aspirin. He never tolerated beta blockers because of symptomatic bradycardia.
On physical exam, you noted his blood pressure as 140/80 with otherwise normal vital signs. He lost 12 pounds since the last visit. There are no significant findings on the rest of the physical exam, including the neurological. On psychiatric exam, a flat affect was observed. His answers were limited to “yes” and “no” with very poor eye contact. On cognitive testing, he was only able to recall two out of three objects. Serial 7’s and orientation were normal.
You reviewed a recent comprehensive metabolic panel, PSA, TSH, and colonoscopy, all of which were essentially normal. A head CT scan at the time of the automobile accident was interpreted as “cerebral atrophy, consistent with age”.
Study, Question 1 of 10